Table 1 Clinical characteristics of PV and ET patients
JAK2V617F | CALR-mutated | ||
|---|---|---|---|
PV | ET | ET | |
No. | 26 | 17 | 7 |
Sex (male/female) | 10/16 (38%/62%) | 5/12 (29%/71%) | 6/1 (86%/14%) |
Age at onset, years, median (range) | 57 (40–77) | 61 (37–72) | 37 (26–72) |
Hemoglobin, g/dL, median (range) | 18.4 (14.3–25.1) | 14.6 (11.9–18.1) | 13.7 (10.6–16.2) |
PLT count, X109/L, median (range) | 460 (210–902) | 677 (481–1168) | 979 (632–1400) |
WBC count, X109/L, median (range) | 9.7 (6.1–89.7) | 8.7 (5.9–18.2) | 8.1 (5.1–10.4) |
Thrombosis at diagnosis, no. (%) | 7 (27) | 3 (18) | 0 (0) |